Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Crucell awarded additional vaccine contract
This contract was awarded by a supranational organization for Latin America and covers sales in 2007. Supranational organizations are major customers for combination vaccines, which are used in
This contract was awarded by a supranational organization for Latin America and covers sales in 2007. Supranational organizations are major customers for combination vaccines, which are used in
The trial will be expanded by 30 to 60 participants, an increase of up to 40% from the number originally planned. The company also has earmarked an additional
The documents relate to the drugs Truvada, Viread and Emtriva. Truvada is a combination of Viread and Emtriva. Truvada is for use in combination with other anti-HIV agents
CTI still plans to continue development of Xyotax despite the setback. The drug has already failed three major lung cancer trials. The company said it would submit a
In two phase III studies telavancin achieved its primary endpoint of non-inferiority in both studies. Telavancin compared favorably to standard therapy in clinical cure, microbiological eradication, and overall
The results were seen in patients who had a recent manic or mixed episode and were then stabilized with the medication for at least six weeks. Abilify is
Uterine fibroids affects roughly half of all women aged 35 to 49. The non-cancerous tumors cause iron-deficiency anemia due to excessive menstrual bleeding. “With no approved treatment for
Specific patient populations include elderly patients who have previously untreated disease or adult patients who have relapsed or refractory disease. Key objectives of the study will be to
The existing agreement between the two companies was signed in 2003. The new expanded agreement, extended till 2010, offers additional opportunities for collaboration, and substantially increases the number
Myocardial ischemia is a condition where there is insufficient blood flow within the heart muscle. Generx represents a new therapeutic class of biologics designed to promote angiogenesis, a